Idarubicin in the Initial Treatment of Adults with Acute Lymphoblastic Leukemia: The Effect of Drug Schedule on Outcome

References

• Berman E., Heller G., Santorsa P. A., McKenzie S., Gee T., Kenipin S., Gulati S., Andreef M., Kolitz I., Gabri-Lovo J., Reich L., Mayer K., Keefe D., Trainor K., Schinger A., Penenberg D., Raymond V., O'Reilly R., Jhanwar S., Young C., Clarkson B. Results of a randomized trial comparing idarubicin and cytohine arabi-noside with daunorubicin and cytosine ardbinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood 1991; 77: 1666–1674
   PubMed Web of Science ®Google Scholar
• Wiernik P. H., Banks P. L. C., Case D. C., Arlin Z. A., Periman P. O., Todd M. B., Ritch P. S., Enck R. E., Weitberg A. B. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia. Blood 1992; 79: 313–319
   PubMed Web of Science ®Google Scholar
• Petti M. C., Mandelli F. ldarubicin in acute leu-kemias: experience of the Italian cooperative group GI-MEMA. Semin. Oncol. 1989; 16(suppl 2)10–15
   PubMedGoogle Scholar
• Gottlicb A. J., Weinberg W., Ellison R. R., Henderson E. S., Terebelo H., Rafla S., Cuttner J., Silver R. T., Carey R. W., Levy R. N., Hutchinson J. L., Raich P., Cooper M. R., Wiernik P., Anderson J. R., Holland J. F. Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by Cancer and Leukemia Group B. Blood 1984; 64: 267–274
   PubMed Web of Science ®Google Scholar
• Linker C. A., Levitt L. J., O'Donnell M., Ries C. A., Link M. P., Forman S. J., Ries C. A. Treatment of adult acute Iymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood. 1991; 78: 2814–2822
   PubMed Web of Science ®Google Scholar
• Radlord J. E., Burns C. P., Jones M. P., Gingrich R. G., Kemp J. D., Edwards R. W., McFadden D. B., Dick F. R., Wen B.-C. Adult acute lymphoblastic leukemia: results of the lowa HOP-L protocol. J. Clin. Oncol. 1989; 7: 58–66
   PubMed Web of Science ®Google Scholar
• Bassan R., Battista R., D'Emilio A., Viero P., Dragone P., Dini E., Barbui T. Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemia. Eur. J. Cancer 1991; 27: 441–447
   PubMed Web of Science ®Google Scholar
• Ellison R. R., Mick R., Cuttner J., Schiffer C. A., Silver R. T., Henderson E. S., Woliver T., Royston I., Davey F. R., Glicksman A. S., Bloomfield C. D., Holland J. F. The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B. J. Clin. Oncol. 1991; 9: 2002–2015
   PubMed Web of Science ®Google Scholar
• Bassan R., Rambaldi A., Viero P., Borleri G., Barbui T. Integrated use of morphology, cytochemistry, and iminune marker analysis to identify acute leukaemia subtypes. Haematologica 1989; 74: 487–490
   PubMedGoogle Scholar
• Sobol R. E., Mick R., Royston I., Davey F. R., Ellison R. R., Newman R., Cuttner J., Griffin J. D., Collins H., Nelson D. A., Bloomfield C. D. Clinical importance or myeloid antigen expression in adult acute lymphoblastic leukemia. N. Engl. J. Med. 1987; 316: 1111–1117
   PubMed Web of Science ®Google Scholar
• Biondi A., Rambaldi A., Pandolfi P. P., Rossi V., Giu-Dici G., Alcalay M., Lo Coco F., Diverio D., Pogliani E. M., Lanzi E. M., Mandelli F., Masera G., Barbui T., Pelicci P. G. Molecular monitoring of the myl/ RAR-a fusion gene in acute promyelocytic leukemia by poly-merase chain reaction. Blood 1992; 80: 492–497
   PubMed Web of Science ®Google Scholar
• Hermans A., Gow J., Selleri L., Von Lindern M., Ha-Gemeijer A., Wiedemann L. M., Grosveld G. bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 1988; 2: 628–633
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Walters R. S., Keating M. J., Smith T. L., O'Brien S., Estey E. H., Huh Y. O., Spinolo J., Dicke K., Barlogie B., McCredie K. B., Freireich E. J. Results of the vincristine, doxorubicin, and dexa-methasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J. Clin. Oncol. 1990; 8: 994–1004
   PubMed Web of Science ®Google Scholar
• Brown R. A., Herzig R. H., Wolff S. N., Frei-Lahr D., Pineiro L., Bolwell B. J., Lowder J. N., Harden E. A., Hande K. R., Herzig G. P. High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy. Blood 1990; 76: 473–479
   PubMed Web of Science ®Google Scholar
• Bassan R., Cornelli P. E., Battista R., Terzi T., Buelli M., Rambaldi A., Viero P., D'Emilio A., Dini E., Barbui T. Intensive retreatment of adults and children with acute lymphoblastic Ieukaemia. Hematol. Oncol. 1992; 10: 105–110
   PubMed Web of Science ®Google Scholar
• Rohatiner A. Z. S., Bassan R., Battista K., Barnett M. J., Gregory W., Lim J., Amess J., Oza A., Barbui T., Horton M., Chisesi T., Lister T. A. High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukemia. Br. J. Cancer 1990; 62: 454–458
   PubMed Web of Science ®Google Scholar
• Bassan R., Battista R., Rohatiner A. Z. S., Love S., Carter M., Buelli M., Viero P., D'Emilio A., Maccallurn P., Amess J., Dini E., Barbui T., Lister T. A. Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period. Leukemia. 1992; 6(Suppl 2)186–190
   PubMed Web of Science ®Google Scholar
• Reid J. M., Pendergrasa T. W., Krailo M. D., Hammond G. D., Ames M. M. Plasma pharinacokinetics and cerebrospinal fluid concentration of idarubicin and ida-rubicinol in pediatric leukemia patients. A Childrens Cancer Study Group report. Concer Res. 1990; 50: 6525–6528
   PubMed Web of Science ®Google Scholar
• Berman E., Weiss M., Kempin S., Gee T., Bertino J., Clarkson B. Intensive therapy for adult acute lymphoblastic leukemia. Semin. Hematol. 1991; 28(Suppl 4)72–75
   PubMedGoogle Scholar
• Cassileth P. A., Bennett J. M. Effectiveness of acute nonlyniphocytic leukemia induction chemotherapy in acute lymphocytic leukemia. Cancer Treat. Rep. 1985; 69: 1439–1440
   PubMedGoogle Scholar
• Barbui T., Rodeghiero F., Meli S., Dini E. Fatal pulmonary embolism and antithrombin III deficiency in adult lymphoblastic leukaemia during L-asparaginase therapy. Acta Haematol. 1983; 69: 188–191
   PubMed Web of Science ®Google Scholar
• Barbui T., Finazzi G., Viganb S., Mannucci P. M. L-asparaginase lowers protein C antigen. Thromb. Haemostas. 1984; 52: 216
   PubMed Web of Science ®Google Scholar
• Nicolson G. L., Custead S. E. Effects of che-motherapeutic drugs on platelet and metastatic tumor cell-en-dothelial cell interactions as a model for assessing vascular endothelial integrity. Cancer Res. 1985; 45: 331–336
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Jackson C. W., Chesncy C. M., Abild-Gaard C. F. lnvolvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukemia. Am. J. Hematol. 1987; 25: 291–298
   PubMed Web of Science ®Google Scholar